MEI Pharma, Inc.
COMBINATION THERAPY
Last updated:
Abstract:
Provided herein are methods of treating diseases, such as cancer, using a combination therapy. In certain embodiments, the methods comprise administering an effective amount of a phosphoinositide-3-kinase (PI3K) inhibitor and an effective amount of a Bruton tyrosine kinase (BTK) inhibitor to a patient.
Status:
Application
Type:
Utility
Filling date:
20 Mar 2019
Issue date:
7 Jan 2021